Panelists discuss how transitioning patients from intravenous (IV) to subcutaneous (SubQ) therapies demands a coordinated, multidisciplinary approach—integrating clinical judgment, electronic medical ...

The certainty of the evidence for the use of deferoxamine for the improvement of neurological outcome in spontaneous intracerebral haemorrhage is low. This is based on two small studies with short ...

Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by skeletal muscle weakness that worsens with activity and improves with rest. This article discusses emerging therapeutic ...

Subcutaneous isatuximab administered via an on-body injector appears to be as safe and effective as intravenous isatuximab in patients with relapsed or refractory multiple myeloma.

Subcutaneous immunotherapy is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.

The LifeSite Hemodialysis Access System was designed as a totally subcutaneous alternative to hemodialysis catheters. It combines port and catheter technology, allowing immediate use on implantation.